They later identified compounds inhibiting TET1 and 5hmC modifications, effectively reducing cell viability in acute myeloid leukemia with high TET1 levels, including t(11q23)/MLL rearrangements and t(8; 21) acute myeloid leukemia.44 This evidence concerns the gene KMT2A and acute myeloid leukemia.